neoplas med GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
neoplas med GmbH - overview
Established
2009
Location
Greifswald, -, Germany
Primary Industry
Medical Devices & Equipment
About
Based in Greifswald, Germany, and founded in 2009, Neoplas Med GmbH is a medical technology company that provides advanced argon cold plasma jet therapy for the treatment of acute and chronic wounds. In November 2024, neoplas med GmbH raised USD 18 million in venture funding from Venture Lab Niterra Group. neoplas med GmbH is focused on improving the treatment of chronic and acute wounds using cold plasma therapy. The compay's product, the kINPen MED, is a cold plasma jet that uses argon to promote wound healing, with antibacterial effects and no known side effects or resistance formation.
The company's technology enables exact treatment even on uneven wound surfaces, and its safety and efficacy have been proven by scientific research. The company is developing this medicine to benefit millions of people who suffer from wound-related diseases. The company plans to use the November 2024 funding to accelerate international expansion and develop its technology platform for treating infected and chronic wounds.
Current Investors
Niterra Corporation Limited, Pegasus Tech Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.neoplas-med.eu
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.